D002753Chemicals & DrugsD03.633.100.221.346550.993941Chlorzoxazoneprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.7497010.04076375research area of0.7542710.1640493subject area forAnesthesia and Critical CareBiochemistry and Molecular Biology32132200Du X, Carvalho-de-Souza JL, Wei C, Carrasquel-Ursulaez W, Lorenzo Y, Gonzalez N, Kubota T, Staisch J, Hain T, Petrossian N, Xu M, Latorre R, Bezanilla F, Gomez CMProceedings of the National Academy of Sciences of the United States of AmericaLoss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc Natl Acad Sci U S A. 2020 03 17; 117(11):6023-6034.Proc Natl Acad Sci U S A2020-03-04T00:00:002020Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.11181893Cao Y, Dreixler JC, Roizen JD, Roberts MT, Houamed KMThe Journal of pharmacology and experimental therapeuticsModulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther. 2001 Mar; 296(3):683-9.J Pharmacol Exp Ther2001-03-01T00:00:002001Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.http://www.researchgate.net/profile/John_Fung2/stats/Research Gatehttp://nerve.bsd.uchicago.eduExcitability, Molecular Basishttps://publons.com/author/1183306/john-fung#profilePublonshttps://www.healthtap.com/#experts/11185863/aboutHealth Taphttps://orcid.org/0000-0002-3038-0441ORCIDhttp://nerve.bsd.uchicago.edu/FBLab SiteNeurologySurgeryUniversity of ChicagoJohn C.DreixlerJohn C. Dreixler41.78927490000000-87.601250000000001086Dreixler, John C.Research Associate ProfessorChristopher M.Gomez1GVmBqQPOeLchGhrbEnp6iv47M/z/LZWeXp7ceLFF3NDChristopher M. Gomez41.78927490000000-87.601250000000001095Gomez, Christopher M.ProfessorXiaofeiDuXiaofei Du41.78927490000000-87.601250000000002352Du, XiaofeiResearch Associate ProfessorFranciscoBezanillaFrancisco Bezanilla41.78927490000000-87.60125000000000987Bezanilla, FranciscoProfessortrue1Research Associate ProfessorResearch Associate Professortrue1ProfessorProfessortrue1Research Associate ProfessorResearch Associate Professortrue1ProfessorProfessortrue1ProfessorProfessorJohnFungJohn Fung0.000000000000000.000000000000003383Fung, JohnProfessor9542473Burckart GJ, Frye RF, Kelly P, Branch RA, Jain A, Fung JJ, Starzl TE, Venkataramanan RClinical pharmacology and therapeuticsInduction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.Clin Pharmacol Ther1998-03-01T00:00:001998Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.